References
- Fraser H. F., Van Horn G. D., Martin W. R., Wolbach A. B., Isbell H. Methods for evaluating addiction liability. (A) “Attitude” of opiate addicts toward opiate-like drugs. (B) A short-term “direct” addiction test. J. Pharmacol. Exp. Therap. 1961; 133: 371–387
- Fraser H. F., Rosenberg D. E. Low addictiveness of two analgesics in the benzomorphan series. Biochem. Pharmacol. (Abstract Supp.) 1963; 12: 6
- Gorodetzky C. W., Martin W. R. A comparison of fentanyl. droperidol and morphine. Clin. Pharmacol. Therap. 1965; 6: 731–739
- Himmelsbach C. K. Studies on the relation of drug addiction to the autonomic nervous system: Results of cold pressor tests. J. Pharmacol. Exp. Therap. 1941; 73: 91–98
- Himmelsbach C. K. Clinical studies of drug addiction. Arch. Intern. Med. 1942; 69: 766–772
- Jaffe J. H., Brill L. Cyclazocine, a long-acting narcotic antagonist: Its voluntary acceptance as a treatment modality by narcotics abusers. International Journal of the Addictions 1966; 1: 99–123
- Martin W. R., Wikler A., Eades C. G., Pescor F. T. Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 1963; 4: 247–260
- Martin W. R., Fraser H. F., Gorodetzky C. W., Rosenberg D. E. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2′-hydroxy-5, 9-dimethyl-6, 7-benzomorphan (cyclazocine, Win 20, 740, ARC II-C-3). J. Pharmacol. Exp. Therap. 1965; 150: 426–436
- Martin W. R., Gorodetzky C. W. Demonstration of tolerance to and physical dependence on N-allylnormorphine (nalorphine). J. Pharmacol. Exp. Therap. 1965; 150: 437–442
- Martin W. R., Gorodetzky C. W., McClane T. K. An experimental study in the treatment of narcotic addicts with cyclazocine. Clin. Pharmacol. Therap. 1966, in press
- Wikler A. Conditioning factors in opiate addiction and relapse. Narcotics, D. M. Wilner, G. G. Kassebaum. McGraw-Hill, New York 1965
- Wikler A., Pescor F. T. Factors disposing to “relapse” in rats previously addicted to morphine. Pharmacologist 1965; 7: 171